Literature DB >> 32052134

Successful treatment of Hodgkin lymphoma-like EBV-associated post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation with nivolumab.

Fumiya Wada1, Tadakazu Kondo2, Momoko Nakamura1, Kazuhisa Chonabayashi1, Momoko Nishikori1, Masakatsu Hishizawa1, Kouhei Yamashita1, Akifumi Takaori-Kondo1.   

Abstract

Entities:  

Year:  2020        PMID： 32052134     DOI： 10.1007/s00277-020-03960-4

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  3 in total

1.  High numbers of programmed cell death-1-positive tumor infiltrating lymphocytes correlate with early onset of post-transplant lymphoproliferative disorder.

Authors:  Hideaki Saito; Hiroaki Miyoshi; Hirohiko Shibayama; Jun Toda; Shinsuke Kusakabe; Michiko Ichii; Jiro Fujita; Kentaro Fukushima; Tetsuo Maeda; Masao Mizuki; Kenji Oritani; Masao Seto; Takafumi Yokota; Yuzuru Kanakura; Naoki Hosen; Koichi Ohshima
Journal:  Int J Hematol       Date:  2021-03-25       Impact factor: 2.490

Review 2.  Post-hematopoietic stem cell transplantation relapse: Role of checkpoint inhibitors.

Authors:  Elham Roshandel; Farzaneh Tavakoli; Sayeh Parkhideh; Sedigheh Sadat Akhlaghi; Maria Tavakoli Ardakani; Masoud Soleimani
Journal:  Health Sci Rep       Date:  2022-03-08

Review 3.  Current Clinical Applications and Future Perspectives of Immune Checkpoint Inhibitors in Non-Hodgkin Lymphoma.

Authors:  John Apostolidis; Ayman Sayyed; Mohammed Darweesh; Panayotis Kaloyannidis; Hani Al Hashmi
Journal:  J Immunol Res       Date:  2020-10-29       Impact factor: 4.818
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.